Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

The tragedy of Thomas Crawford, sculptor of the Statue of Freedom.

Novak RF.

Surv Ophthalmol. 2015 Jul-Aug;60(4):378-82. doi: 10.1016/j.survophthal.2014.11.003. Epub 2014 Dec 13.

PMID:
25891030
3.

Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review.

Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M, Jacobs D, Köhrle J, Lee DH, Rylander L, Rignell-Hydbom A, Tornero-Velez R, Turyk ME, Boyles AL, Thayer KA, Lind L.

Environ Health Perspect. 2013 Jul;121(7):774-83. doi: 10.1289/ehp.1205502. Epub 2013 May 7. Review.

4.

Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells.

Zheng J, Hudder A, Zukowski K, Novak RF.

Cancer Lett. 2010 Oct 1;296(1):74-87. doi: 10.1016/j.canlet.2010.03.018. Epub 2010 Apr 22.

5.
6.

Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.

Kim SH, Miller FR, Tait L, Zheng J, Novak RF.

Int J Cancer. 2009 Jun 15;124(12):2813-28. doi: 10.1002/ijc.24278.

7.

miRNAs: effectors of environmental influences on gene expression and disease.

Hudder A, Novak RF.

Toxicol Sci. 2008 Jun;103(2):228-40. doi: 10.1093/toxsci/kfn033. Epub 2008 Feb 16. Review.

8.
9.
10.
11.
12.

Role of mechanical and redox stress in activation of mitogen-activated protein kinases in primary cultured rat hepatocytes.

Kim SK, Woodcroft KJ, Oh SJ, Abdelmegeed MA, Novak RF.

Biochem Pharmacol. 2005 Dec 5;70(12):1785-95. Epub 2005 Oct 20.

PMID:
16242670
13.

Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.

Sander M, Cadet J, Casciano DA, Galloway SM, Marnett LJ, Novak RF, Pettit SD, Preston RJ, Skare JA, Williams GM, Van Houten B, Gollapudi BB.

Toxicol Appl Pharmacol. 2005 Oct 1;208(1):1-20.

PMID:
16164957
14.

Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes.

Abdelmegeed MA, Carruthers NJ, Woodcroft KJ, Kim SK, Novak RF.

J Pharmacol Exp Ther. 2005 Oct;315(1):203-13. Epub 2005 Jun 24.

15.

Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes.

Kim SK, Woodcroft KJ, Khodadadeh SS, Novak RF.

J Pharmacol Exp Ther. 2004 Oct;311(1):99-108. Epub 2004 May 28.

16.
17.

Gene-specific dye bias in microarray reference designs.

Dombkowski AA, Thibodeau BJ, Starcevic SL, Novak RF.

FEBS Lett. 2004 Feb 27;560(1-3):120-4.

18.
19.

Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD).

Starcevic SL, Diotte NM, Zukowski KL, Cameron MJ, Novak RF.

Toxicol Sci. 2003 Sep;75(1):74-81. Epub 2003 Jun 12.

PMID:
12805649
20.

Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes.

Kim SK, Woodcroft KJ, Novak RF.

J Pharmacol Exp Ther. 2003 Apr;305(1):353-61.

22.

Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression.

Woodcroft KJ, Hafner MS, Novak RF.

Hepatology. 2002 Feb;35(2):263-73.

PMID:
11826398
23.

Kepone (chlordecone) disrupts adherens junctions in human breast epithelial cells cultured on matrigel.

Starcevic SL, Bortolin S, Woodcroft KJ, Novak RF.

In Vivo. 2001 Jul-Aug;15(4):289-94.

PMID:
11695219
24.

Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.

Starcevic SL, Elferink C, Novak RF.

J Natl Cancer Inst. 2001 May 16;93(10):776-82.

PMID:
11353788
25.

Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment.

Kim H, Putt DA, Zangar RC, Wolf CR, Guengerich FP, Edwards RJ, Hollenberg PF, Novak RF.

Drug Metab Dispos. 2001 Mar;29(3):353-60.

26.
27.

The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression.

Novak RF, Woodcroft KJ.

Arch Pharm Res. 2000 Aug;23(4):267-82. Review.

PMID:
10976571
28.
29.

Identification of a ubiquitination-Target/Substrate-interaction domain of cytochrome P-450 (CYP) 2E1.

Banerjee A, Kocarek TA, Novak RF.

Drug Metab Dispos. 2000 Feb;28(2):118-24.

30.
32.

Cellular distribution of cytochromes P-450 in the rat kidney.

Cummings BS, Zangar RC, Novak RF, Lash LH.

Drug Metab Dispos. 1999 Apr;27(4):542-8.

33.

Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide.

Zangar RC, Novak RF.

Arch Biochem Biophys. 1998 May 1;353(1):1-9.

PMID:
9578594
34.
35.

Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes.

Woodcroft KJ, Novak RF.

Chem Biol Interact. 1997 Nov 6;107(1-2):75-91.

PMID:
9402951
36.

Posttranscriptional elevation of cytochrome P450 3A expression.

Zangar RC, Hernandez M, Novak RF.

Biochem Biophys Res Commun. 1997 Feb 3;231(1):203-5.

PMID:
9070249
38.
39.

Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells.

Shen K, Novak RF.

Biochem Biophys Res Commun. 1997 Jan 3;230(1):89-93.

PMID:
9020068
40.
41.

Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.

Zangar RC, Woodcroft KJ, Novak RF.

Toxicol Appl Pharmacol. 1996 Nov;141(1):110-6.

PMID:
8917682
42.

Effects of hydrazine, phenelzine, and hydralazine treatment on rat hepatic and renal drug-metabolizing enzyme expression.

Runge-Morris M, Feng Y, Zangar RC, Novak RF.

Drug Metab Dispos. 1996 Jul;24(7):734-7.

PMID:
8818569
43.

Differential expression of glutathione S-transferase isoforms in compartments of the testis and segments of the epididymis of the rat.

Gandy J, Primiano T, Novak RF, Kelce WR, York JL.

Drug Metab Dispos. 1996 Jul;24(7):725-33.

PMID:
8818568
45.

Gender-specific and developmental differences in protein kinase C isozyme expression in rat liver.

Zangar RC, Reiners JJ Jr, Novak RF.

Carcinogenesis. 1995 Oct;16(10):2593-7.

PMID:
7586172
46.

3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue.

Kim H, Reddy S, Novak RF.

Drug Metab Dispos. 1995 Aug;23(8):818-24.

PMID:
7493548
47.

Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.

Zangar RC, Woodcroft KJ, Kocarek TA, Novak RF.

Drug Metab Dispos. 1995 Jul;23(7):681-7.

PMID:
7587954
48.

Pyridine induction of Sprague-Dawley rat renal cytochrome P4502E1: immunohistochemical localization and quantitation.

Hotchkiss JA, Kim H, Hahn FF, Novak RF, Dahl AR.

Toxicol Lett. 1995 Jun;78(1):1-7.

PMID:
7604394
49.

Induction of nasal carboxylesterase in F344 rats following inhalation exposure to pyridine.

Nikula KJ, Novak RF, Chang IY, Dahl AR, Kracko DA, Zangar RC, Kim SG, Lewis JL.

Drug Metab Dispos. 1995 May;23(5):529-35.

PMID:
7587926
50.

Determination of the poly(A) tail lengths of a single mRNA species in total hepatic RNA.

Zangar RC, Hernandez M, Kocarek TA, Novak RF.

Biotechniques. 1995 Mar;18(3):465-9.

PMID:
7779397

Supplemental Content

Loading ...
Support Center